NCT04328324

Brief Summary

Upper Gastrointestinal (UGI) symptoms are among the commonest complaints for which patients seek medical attention, with the annual prevalence of dyspepsia approximating 25% . Endoscopy holds an important place in the diagnosis of UGI conditions by enabling visualization, photography, ultrasonography, and biopsying of suspicious lesions . It gives a better diagnostic yield over radiology particularly in the investigation of upper gastrointestinal bleeding, inflammatory conditions of the upper gastro-intestinal track like esophagitis, gastritis and duodenitis as well as the diagnosis of Mallory Weiss tears and vascular malformations .Dyspepsia in the absence of any other symptom was the indication for UGIE in the vast majority of patients. Close to 80% of our patients presented with dyspepsia not associated with any other symptom and in 50% of the patients the endoscopic findings were normal \[4\]. Other common reasons for UGIE were GERD symptoms, recurrent vomiting, dyspepsia associated with weight loss and patients with symptoms of UGI bleeding . Gastritis was the most frequent endoscopic finding in our patients, followed by duodenitis .Gastric ulcer was diagnosed more frequently than duodenal ulcers . Taking a biopsy is very helpful in diagnosis in our study. H. pylori colonization of the gut is the main cause of chronic gastritis and the principal etiological agent of gastric cancer and peptic ulcer disease . Gastric cancer was diagnosed, by endoscopy, about eight times more frequently in patients presenting with an alarm symptom like recurrent vomiting, dyspepsia together with weight loss or UGI bleeding .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2020

Completed
2 days until next milestone

Study Start

First participant enrolled

March 30, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 31, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2021

Completed
Last Updated

March 31, 2020

Status Verified

March 1, 2020

Enrollment Period

1 month

First QC Date

March 28, 2020

Last Update Submit

March 28, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pattern of upper gastrointestinal lesions

    We will see what common GIT lesions happen in patients of upper Egypt

    1 year

Interventions

EndoscopyPROCEDURE

Diagnostic upper Git endoscopy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patient undergoing elective and urgent upper GIT endoscopy either therapeutic or diagnostic. In elrajhi endoscopy unit

You may qualify if:

  • \- All patient undergoing elective and urgent upper GIT endoscopy either therapeutic or diagnostic.

You may not qualify if:

  • Patient undergoing endoscopic intervention for previously detected endoscopic lesion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Endoscopy

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
RHMHasanen

Study Record Dates

First Submitted

March 28, 2020

First Posted

March 31, 2020

Study Start

March 30, 2020

Primary Completion

May 1, 2020

Study Completion

April 30, 2021

Last Updated

March 31, 2020

Record last verified: 2020-03